Indivisor names Joe Ciaffoni CEO; proposes incentive plan with share price targets up to $35

Indivior Pharmaceuticals, Inc.

Joe Ciaffoni to become CEO effective upon shareholder approval of new Directors' Remuneration Policy at May 8, 2025 AGM.
On-hire PSU award up to 1.575M shares vests based on VWAP targets: $15, $20, $25, $30, $35 over 1–5 years.
On-hire RSU award of 525,000 shares with cliff vest on 3rd anniversary of start date.
Proposed policy increases LTIP on-target grant to 400% of salary in 2026 and 700% in 2027.
Benchmarked vs US biopharma peers; CEO's potential dilution <2% of value created for shareholders.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.